Key result
Lisinopril alone and lisinopril plus simvastatin increased catalase and decreased glutathione peroxidase activity in 94% to 100% of patients after 12 and 24 weeks of treatment.
Why the study?
Does lisinopril plus simvastatin compared to lisinopril alone modify erythrocyte antioxidant and energy metabolic enzymes in patients with atherosclerosis and moderate hypertension?
RCT
Randomized
Does lisinopril plus simvastatin compared to lisinopril alone modify erythrocyte antioxidant and energy metabolic enzymes in patients with atherosclerosis and moderate hypertension?
Lisinopril monotherapy and combined lisinopril plus simvastatin therapy exhibit specific and pronounced effects on antioxidant and energy metabolic enzyme activities in erythrocytes of hypertensive patients.
Answers are grounded in this paper and cite their sources.
Lisinopril modulates erythrocyte antioxidant enzymes with or without simvastatin; extends pleiotropic effect data in hypertensive atherosclerosis.
Angiotensin-converting enzyme inhibitors are effective at reducing blood pressure, whereas statins decrease plasma cholesterol impeding atherosclerosis. It is hypothesized that these medications may improve blood pressure and serum cholesterol by modifying the antioxidative status and energy metabolism of erythrocytes. In this study, the effects of 2 treatments are compared: lisinopril alone versus lisinopril + simvastatin, on erythrocyte antioxidant and energy metabolic enzymes. Patients with atherosclerosis and moderate hypertension are randomly assigned to receive lisinopril 10 to 20 mg/d or lisinopril 10 to 20 mg/d plus simvastatin 20 mg/d for 24 weeks. Higher catalase activity and lower glutathione peroxidase activity are observed in 94% to 100% patients from both groups after 12 and 24 weeks of treatment. Superoxide dismutase activity is increased significantly only after 24 weeks. No changes of glutathione reductase, lactate dehydrogenase, and phosphofructokinase activities are found under any conditions indicated. Both treatments decrease systolic and diastolic blood pressure equally. Only lisinopril + simvastatin treatment decreases plasma total cholesterol and low-density lipoprotein cholesterol. The results show for the first time that lisinopril monotherapy and combined lisinopril + simvastatin therapy exhibit specific and pronounced effects on antioxidant and energy metabolic enzyme activities in erythrocytes of hypertensive patients.
No takes yet. Share an insight, caveat, or question.
Kaminsky et al. (2009) conducted an RCT in Atherosclerosis and moderate hypertension. Lisinopril plus simvastatin vs. Lisinopril 10 to 20 mg/d was evaluated on Erythrocyte antioxidant and energy metabolic enzyme activities. Lisinopril alone and lisinopril plus simvastatin increased catalase and decreased glutathione peroxidase activity in 94% to 100% of patients after 12 and 24 weeks of treatment.
Synapse has enriched 10 related papers. Consider them for comparative context: